Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2185 | 2019 |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 902 | 2017 |
Donanemab in early Alzheimer’s disease MA Mintun, AC Lo, C Duggan Evans, AM Wessels, PA Ardayfio, ... New England Journal of Medicine 384 (18), 1691-1704, 2021 | 831 | 2021 |
Identification of common variants associated with human hippocampal and intracranial volumes JL Stein, SE Medland, AA Vasquez, DP Hibar, RE Senstad, AM Winkler, ... Nature genetics 44 (5), 552-561, 2012 | 698 | 2012 |
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data PM Thompson, JL Stein, SE Medland, DP Hibar, AA Vasquez, ... Brain imaging and behavior 8, 153-182, 2014 | 664 | 2014 |
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps LG Apostolova, RA Dutton, ID Dinov, KM Hayashi, AW Toga, ... Archives of neurology 63 (5), 693-699, 2006 | 663 | 2006 |
Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature LG Apostolova, JL Cummings Dementia and geriatric cognitive disorders 25 (2), 115-126, 2008 | 544 | 2008 |
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study JM Ringman, SA Frautschy, E Teng, AN Begum, J Bardens, M Beigi, ... Alzheimer's research & therapy 4, 1-8, 2012 | 509 | 2012 |
Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial JR Sims, JA Zimmer, CD Evans, M Lu, P Ardayfio, JD Sparks, AM Wessels, ... Jama 330 (6), 512-527, 2023 | 396 | 2023 |
Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease LG Apostolova, AE Green, S Babakchanian, KS Hwang, YY Chou, ... Alzheimer Disease & Associated Disorders 26 (1), 17-27, 2012 | 382 | 2012 |
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal LG Apostolova, L Mosconi, PM Thompson, AE Green, KS Hwang, ... Neurobiology of aging 31 (7), 1077-1088, 2010 | 334 | 2010 |
Alzheimer disease LG Apostolova Continuum: Lifelong Learning in Neurology 22 (2), 419-434, 2016 | 332 | 2016 |
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ... Neurology 85 (14), 1240-1249, 2015 | 332 | 2015 |
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease LG Apostolova, ID Dinov, RA Dutton, KM Hayashi, AW Toga, ... Brain 129 (11), 2867-2873, 2006 | 327 | 2006 |
New insights into atypical Alzheimer's disease in the era of biomarkers J Graff-Radford, KXX Yong, LG Apostolova, FH Bouwman, M Carrillo, ... The Lancet Neurology 20 (3), 222-234, 2021 | 301 | 2021 |
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations JM Ringman, J O’Neill, D Geschwind, L Medina, LG Apostolova, ... Brain 130 (7), 1767-1776, 2007 | 298 | 2007 |
Aducanumab: appropriate use recommendations J Cummings, P Aisen, LG Apostolova, A Atri, S Salloway, M Weiner The journal of prevention of Alzheimer's disease 8, 398-410, 2021 | 285 | 2021 |
Comparison of AdaBoost and support vector machines for detecting Alzheimer's disease through automated hippocampal segmentation JH Morra, Z Tu, LG Apostolova, AE Green, AW Toga, PM Thompson IEEE transactions on medical imaging 29 (1), 30-43, 2009 | 285 | 2009 |
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls JH Morra, Z Tu, LG Apostolova, AE Green, C Avedissian, SK Madsen, ... Neuroimage 45 (1), S3-S15, 2009 | 283 | 2009 |
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease DA Wolk, BC Dickerson, Alzheimer’s Disease Neuroimaging Initiative, ... Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010 | 274 | 2010 |